trial · primary record
JNJ-81201887
Geographic Atrophy
| Phase | Phase 2, Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 274 |
| Primary completion | 2030-07-16 |
| Primary endpoint | Number of Participants with Ocular and Systemic Treatment-emergent Adverse Events (TEAEs) |
| Registry ID | NCT06635148 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:47.733Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06635148
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.